These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11964533)

  • 21. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral Therapy Use, Medication Adherence, and Viral Suppression Among PLWHA with Panic Symptoms.
    Sam TS; Hutton HE; Lau B; McCaul ME; Keruly J; Moore R; Chander G
    AIDS Behav; 2015 Nov; 19(11):2049-56. PubMed ID: 25903506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of intimate partner violence on clinic attendance, viral suppression and CD4 cell count of women living with HIV in an urban clinic setting.
    Anderson JC; Campbell JC; Glass NE; Decker MR; Perrin N; Farley J
    AIDS Care; 2018 Apr; 30(4):399-408. PubMed ID: 29397777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.
    Mellins CA; Havens JF; McDonnell C; Lichtenstein C; Uldall K; Chesney M; Santamaria EK; Bell J
    AIDS Care; 2009 Feb; 21(2):168-77. PubMed ID: 19229685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.
    Hinkin CH; Hardy DJ; Mason KI; Castellon SA; Durvasula RS; Lam MN; Stefaniak M
    AIDS; 2004 Jan; 18 Suppl 1(Suppl 1):S19-25. PubMed ID: 15075494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
    Baum MK; Rafie C; Lai S; Sales S; Page B; Campa A
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):93-9. PubMed ID: 19295339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients.
    Paydary K; Ekhtiari H; Noori M; Rad MV; Hajiabdolbaghi M; SeyedAlinaghi S
    Infect Disord Drug Targets; 2015; 15(3):177-83. PubMed ID: 26411558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective.
    Paasche-Orlow MK; Cheng DM; Palepu A; Meli S; Faber V; Samet JH
    J Gen Intern Med; 2006 Aug; 21(8):835-40. PubMed ID: 16881943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users.
    Macalino GE; Hogan JW; Mitty JA; Bazerman LB; Delong AK; Loewenthal H; Caliendo AM; Flanigan TP
    AIDS; 2007 Jul; 21(11):1473-7. PubMed ID: 17589194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
    Nachega JB; Hislop M; Dowdy DW; Gallant JE; Chaisson RE; Regensberg L; Maartens G
    AIDS; 2008 Oct; 22(16):2117-25. PubMed ID: 18832875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics.
    Henrich TJ; Lauder N; Desai MM; Sofair AN
    J Community Health; 2008 Apr; 33(2):69-77. PubMed ID: 18046634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems.
    Kim TW; Palepu A; Cheng DM; Libman H; Saitz R; Samet JH
    AIDS Care; 2007 Sep; 19(8):1039-47. PubMed ID: 17852002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.
    Bratt G; Karlsson A; Leandersson AC; Albert J; Wahren B; Sandström E
    AIDS; 1998 Nov; 12(16):2193-202. PubMed ID: 9833861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial.
    Parsons JT; Golub SA; Rosof E; Holder C
    J Acquir Immune Defic Syndr; 2007 Dec; 46(4):443-50. PubMed ID: 18077833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.